07
Nov
Nov
A modern discovery in the field of pancreatic cancer treatment has been revealed, revealing epigenetic silencing of BEND4 as a potential synthetic lethal marker increasing the effectiveness of ATM inhibitors in the treatment of pancreatic cancer. This novel study provides a breakthrough approach to targeting the tumor suppressor gene, BEND4, which is often methylated and […]